{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:35:00Z","timestamp":1778618100617,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1124\/jpet.112.199497","type":"journal-article","created":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T12:17:16Z","timestamp":1349957836000},"page":"141-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive\/Antidementia Agents"],"prefix":"10.1016","volume":"344","author":[{"given":"Alene T.","family":"McCoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline C.","family":"Benoist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leen H.","family":"Kawas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyote M.","family":"Bule-Ghogare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne M.","family":"Appleyard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary A.","family":"Wayman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph W.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.112.199497_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-3565(25)22314-X","article-title":"Metabolism of angiotensins II and III by membrane-bound peptidases from rat brain","volume":"245","author":"Abhold","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.199497_bib2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/cercor\/bhp133","article-title":"Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning","volume":"20","author":"Balschun","year":"2010","journal-title":"Cereb Cortex"},{"key":"10.1124\/jpet.112.199497_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1515\/DMDI.2008.23.3-4.329","article-title":"In vitro evaluation of hepatic and extra-hepatic metabolism of coumarins using rat subcellular fractions: correlation of in vitro clearance with in vivo data","volume":"23","author":"Behera","year":"2008","journal-title":"Drug Metabol Drug Interact"},{"key":"10.1124\/jpet.112.199497_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/jpet.111.182220","article-title":"Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs","volume":"339","author":"Benoist","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.199497_bib5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0306-4522(88)90182-0","article-title":"Angiotensin II-(3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats","volume":"27","author":"Braszko","year":"1988","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.112.199497_bib6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/dneu.20759","article-title":"Nerve growth factor as a paradigm of neurotrophins related to Alzheimer\u2019s disease","volume":"70","author":"Calissano","year":"2010","journal-title":"Dev Neurobiol"},{"key":"10.1124\/jpet.112.199497_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1755-5949.2008.00057.x","article-title":"Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy","volume":"14","author":"De Bundel","year":"2008","journal-title":"CNS Neurosci Ther"},{"key":"10.1124\/jpet.112.199497_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0006-8993(88)91279-6","article-title":"Effects of aminopeptidase inhibition on the half-lives of [125I]angiotensins in the cerebroventricles of the rat","volume":"448","author":"Dewey","year":"1988","journal-title":"Brain Res"},{"key":"10.1124\/jpet.112.199497_bib9","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/jps.20076","article-title":"Experimental design on single-time-point high-throughput microsomal stability assay","volume":"93","author":"Di","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.112.199497_bib10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0896-6273(00)80247-0","article-title":"Hepatocyte growth factor\/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons","volume":"17","author":"Ebens","year":"1996","journal-title":"Neuron"},{"key":"10.1124\/jpet.112.199497_bib11","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1126\/science.290.5495.1364","article-title":"PSD-95 involvement in maturation of excitatory synapses","volume":"290","author":"El-Husseini","year":"2000","journal-title":"Science"},{"key":"10.1124\/jpet.112.199497_bib12","first-page":"329","article-title":"Cerebroprotective effect of angiotensin IV in experimental ischemic stroke in the rat mediated by AT(4) receptors","volume":"57","author":"Faure","year":"2006","journal-title":"J Physiol Pharmacol"},{"key":"10.1124\/jpet.112.199497_bib13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00018-002-8451-5","article-title":"The synapsins: beyond the regulation of neurotransmitter release","volume":"59","author":"Ferreira","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/jpet.112.199497_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1385\/JMN:20:3:349","article-title":"M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer\u2019s disease: implications in future therapy","volume":"20","author":"Fisher","year":"2003","journal-title":"J Mol Neurosci"},{"key":"10.1124\/jpet.112.199497_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1517\/14728222.8.1.7","article-title":"Angiotensin as a target for the treatment of Alzheimer\u2019s disease, anxiety and depression","volume":"8","author":"Gard","year":"2004","journal-title":"Expert Opin Ther Targets"},{"issue":"Suppl 2","key":"10.1124\/jpet.112.199497_bib16","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1186\/1471-2202-9-S2-S15","article-title":"Cognitive-enhancing effects of angiotensin IV","volume":"9","author":"Gard","year":"2008","journal-title":"BMC Neurosci"},{"key":"10.1124\/jpet.112.199497_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.tins.2010.01.001","article-title":"Structural dynamics of dendritic spines in memory and cognition","volume":"33","author":"Kasai","year":"2010","journal-title":"Trends Neurosci"},{"key":"10.1124\/jpet.112.199497_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2174\/187152409789630406","article-title":"Efficacy of HGF gene transfer for various nervous injuries and disorders","volume":"9","author":"Kato","year":"2009","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"10.1124\/jpet.112.199497_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/jpet.111.188136","article-title":"Development of angiotensin IV analogs as hepatocyte growth factor\/Met modifiers","volume":"340","author":"Kawas","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.199497_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1124\/jpet.111.185694","article-title":"Mimics of the dimerization domain of hepatocyte growth factor exhibit anti-Met and anticancer activity","volume":"339","author":"Kawas","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.199497_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0006-8993(01)02100-X","article-title":"The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro","volume":"897","author":"Kram\u00e1r","year":"2001","journal-title":"Brain Res"},{"key":"10.1124\/jpet.112.199497_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0167-0115(96)02116-7","article-title":"Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes","volume":"68","author":"Kram\u00e1r","year":"1997","journal-title":"Regul Pept"},{"key":"10.1124\/jpet.112.199497_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-0115(96)00121-8","article-title":"Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist","volume":"67","author":"Krebs","year":"1996","journal-title":"Regul Pept"},{"key":"10.1124\/jpet.112.199497_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuroscience.2003.12.006","article-title":"Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats","volume":"124","author":"Lee","year":"2004","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.112.199497_bib25","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1124\/dmd.106.010793","article-title":"Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes","volume":"34","author":"Lu","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.199497_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.a.20022","article-title":"Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images","volume":"58","author":"Meijering","year":"2004","journal-title":"Cytometry A"},{"key":"10.1124\/jpet.112.199497_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3317\/jraas.2001.032","article-title":"Bioactive angiotensin peptides: focus on angiotensin IV","volume":"2","author":"Mustafa","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1124\/jpet.112.199497_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrd3366","article-title":"Potential therapeutic uses of BDNF in neurological and psychiatric disorders","volume":"10","author":"Nagahara","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.112.199497_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0167-0115(01)00312-3","article-title":"A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits","volume":"102","author":"Pederson","year":"2001","journal-title":"Regul Pept"},{"key":"10.1124\/jpet.112.199497_bib30","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/jms.917","article-title":"A novel approach to perform metabolite screening during the quantitative LC-MS\/MS analyses of in vitro metabolic stability samples using a hybrid triple-quadrupole linear ion trap mass spectrometer","volume":"40","author":"Shou","year":"2005","journal-title":"J Mass Spectrom"},{"key":"10.1124\/jpet.112.199497_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0006-8993(95)01589-2","article-title":"Effects of discrete kainic acid-induced hippocampal lesions on spatial and contextual learning and memory in rats","volume":"716","author":"Stubley-Weatherly","year":"1996","journal-title":"Brain Res"},{"key":"10.1124\/jpet.112.199497_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-002-0655-3","article-title":"Angiotensin IV in the central nervous system","volume":"311","author":"von Bohlen und Halbach","year":"2003","journal-title":"Cell Tissue Res"},{"key":"10.1124\/jpet.112.199497_bib33","doi-asserted-by":"crossref","first-page":"9093","DOI":"10.1073\/pnas.0803072105","article-title":"An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP","volume":"105","author":"Wayman","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.112.199497_bib34","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.neuron.2006.05.008","article-title":"Activity-dependent dendritic arborization mediated by CaM-kinase I activation and enhanced CREB-dependent transcription of Wnt-2","volume":"50","author":"Wayman","year":"2006","journal-title":"Neuron"},{"key":"10.1124\/jpet.112.199497_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(95)01454-3","article-title":"Effects of LY231617 and angiotensin IV on ischemia-induced deficits in circular water maze and passive avoidance performance in rats","volume":"717","author":"Wright","year":"1996","journal-title":"Brain Res"},{"key":"10.1124\/jpet.112.199497_bib36","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.expneurol.2009.09.012","article-title":"The brain RAS and Alzheimer\u2019s disease","volume":"223","author":"Wright","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1124\/jpet.112.199497_bib37","first-page":"R514","article-title":"Pressor action and dipsogenicity induced by angiotensin II and III in rats","volume":"249","author":"Wright","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.112.199497_bib38","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1523\/JNEUROSCI.19-10-03952.1999","article-title":"Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning","volume":"19","author":"Wright","year":"1999","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.112.199497_bib39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/brainsci2030298","article-title":"The angiotensin IV analogue and hepatocyte growth factor\/c-Met antagonist, divalinal-AngIV, attenuates the acquisition of methamphetamine-dependent condition place preference in rats","volume":"2","author":"Wright","year":"2012","journal-title":"Brain Sci"},{"key":"10.1124\/jpet.112.199497_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/jpet.109.161711","article-title":"The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor\/c-Met inhibitor","volume":"333","author":"Yamamoto","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.199497_bib41","doi-asserted-by":"crossref","first-page":"13592","DOI":"10.1523\/JNEUROSCI.0603-08.2008","article-title":"Principles of long-term dynamics of dendritic spines","volume":"28","author":"Yasumatsu","year":"2008","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.112.199497_bib42","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1146\/annurev.neuro.24.1.1071","article-title":"Morphological changes in dendritic spines associated with long-term synaptic plasticity","volume":"24","author":"Yuste","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.1124\/jpet.112.199497_bib43","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1471-4159.2012.07830.x","article-title":"7,8-dihydroxyflavone rescues spatial memory and synaptic plasticity in cognitively impaired aged rats","volume":"122","author":"Zeng","year":"2012","journal-title":"J Neurochem."}],"updated-by":[{"DOI":"10.1124\/jpet.112.199497concern","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"record-id":"32547"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652418473X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652418473X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.112.199497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:17:30Z","timestamp":1739985450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652418473X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S002235652418473X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.112.199497","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive\/Antidementia Agents","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.112.199497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}